Home LiteratureArticle Details
PMID: 8202487 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.

Slebos RJ, Lee MH, Plunkett BS, Kessis TD, Williams BO, Jacks T, Hedrick L, Kastan MB, Cho KR

Abstract

The cell cycle regulatory tumor suppressor proteins p53 and pRB are targeted for inactivation by several tumor viruses, including the high-risk types of human papillomaviruses (HPVs) via interactions of the HPV E6 and E7 oncoproteins with p53 and pRB, respectively. p53 plays a central role in a signal transduction pathway that mediates G1 arrest after DNA damage, though the mechanism by which G1 arrest occurs has not been elucidated. The cyclin-associated protein p21waf1/cip1 has recently been shown to be induced by p53 and to inhibit cyclin complex-mediated phosphorylation of pRB in vitro. Thus, we investigated a possible role for pRB in the p53-mediated DNA damage response. After gamma-irradiation, cells expressing wild-type p53 arrested in G1, contained increased levels of WAF1/CIP1 mRNA, and demonstrated accumulation of hypophosphorylated pRB. In contrast, cell lines with abnormal p53 genes or with p53 functionally inactivated by the E6 oncoprotein of HPV16 (a high-risk HPV) failed to arrest in G1, did not elevate WAF1/CIP1 mRNA, and did not accumulate hypophosphorylated pRB. Despite apparently normal elevation of p53 protein and WAF1/CIP1 mRNA after irradiation, cells expressing HPV16 E7 also failed to arrest in G1 and did not accumulate hypophosphorylated pRB. Disruption of RB genes alone did not totally abrogate this G1 arrest. Our results suggest that p53 indirectly regulates phosphorylation of pRB and that pRB and/or other pRB-like molecules that bind to HPV16 E7 participate in the DNA damage-mediated G1 arrest signal. In the process of HPV infection, the HPV E6 and E7 oncoproteins may undermine this cell cycle checkpoint, contributing to the accumulation of genetic alterations during tumorigenesis.

Related Genes
MeSH Terms
Cell Cycle Cell Line Cyclin-Dependent Kinase Inhibitor p21 Cyclins DNA Damage Gene Expression Humans Oncogene Proteins, Viral/physiology Papillomaviridae Papillomavirus E7 Proteins Phosphorylation Proteins/physiology RNA, Messenger/genetics Repressor Proteins Retinoblastoma Protein/physiology Transfection Tumor Suppressor Protein p53/physiology
Chemicals
CDKN1A protein, human Cyclin-Dependent Kinase Inhibitor p21 Cyclins E6 protein, Human papillomavirus type 16 Oncogene Proteins, Viral Papillomavirus E7 Proteins Proteins RNA, Messenger Repressor Proteins Retinoblastoma Protein Tumor Suppressor Protein p53 oncogene protein E7, Human papillomavirus type 16
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Slebos R J
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Lee M H
Plunkett B S
Kessis T D
Williams B O
Jacks T
Hedrick L
Kastan M B
Cho K R
References (45)
45 references, click to expand
  1. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
    Proc Natl Acad Sci U S A. 1992 May 15;89(10):4549-53 PMID: 1316611
  2. Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.
    Mol Cell Biol. 1992 May;12(5):1905-14 PMID: 1314947
  3. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
    Oncogene. 1992 Sep;7(9):1681-6 PMID: 1323816
  4. Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7491-5 PMID: 1323840
  5. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.
    Cell. 1992 Sep 18;70(6):923-35 PMID: 1356076
  6. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.
    Cell. 1992 Sep 18;70(6):937-48 PMID: 1525830
  7. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
    Genes Dev. 1992 Oct;6(10):1874-85 PMID: 1398067
  8. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.
    Science. 1992 Oct 16;258(5081):424-9 PMID: 1411535
  9. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.
    Cell. 1992 Nov 13;71(4):587-97 PMID: 1423616
  10. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins.
    J Virol. 1992 Dec;66(12):6893-902 PMID: 1331501
  11. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
    Nucleic Acids Res. 1992 Nov 25;20(22):5947-54 PMID: 1461728
  12. Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels.
    Cell Growth Differ. 1992 Nov;3(11):791-802 PMID: 1334693
  13. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents.
    Oncogene. 1993 Feb;8(2):307-18 PMID: 8426740
  14. Human papillomavirus type 16 E7 regulates E2F and contributes to mitogenic signalling.
    Oncogene. 1993 Apr;8(4):893-8 PMID: 8455943
  15. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response.
    EMBO J. 1993 Mar;12(3):1013-20 PMID: 8458319
  16. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation.
    J Virol. 1993 May;67(5):2521-8 PMID: 8386265
  17. p53 is required for radiation-induced apoptosis in mouse thymocytes.
    Nature. 1993 Apr 29;362(6423):847-9 PMID: 8479522
  18. Thymocyte apoptosis induced by p53-dependent and independent pathways.
    Nature. 1993 Apr 29;362(6423):849-52 PMID: 8479523
  19. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer.
    Oncogene. 1993 May;8(5):1397-401 PMID: 8479757
  20. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
    Proc Natl Acad Sci U S A. 1993 May 1;90(9):3988-92 PMID: 8387205
  21. HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p53.
    Oncogene. 1993 Jun;8(6):1697-702 PMID: 8389035
  22. Transcriptional repression by the Rb-related protein p107.
    Mol Biol Cell. 1993 Apr;4(4):389-96 PMID: 7685208
  23. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.
    Genes Dev. 1993 Jul;7(7A):1111-25 PMID: 8319904
  24. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.
    Genes Dev. 1993 Aug;7(8):1572-83 PMID: 8101826
  25. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes.
    FASEB J. 1993 Jul;7(10):872-9 PMID: 8393818
  26. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage.
    Cancer Res. 1993 Sep 15;53(18):4164-8 PMID: 8364909
  27. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  28. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  29. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells.
    Oncogene. 1993 Dec;8(12):3307-12 PMID: 8247533
  30. Braking the cycle.
    Cell. 1993 Dec 3;75(5):839-41 PMID: 8252620
  31. Cell cycle-specific association of E2F with the p130 E1A-binding protein.
    Genes Dev. 1993 Dec;7(12A):2392-404 PMID: 8253385
  32. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.
    Mol Cell Biol. 1994 Mar;14(3):1815-23 PMID: 8114714
  33. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.
    Exp Cell Res. 1994 Mar;211(1):90-8 PMID: 8125163
  34. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
    Anal Biochem. 1987 Apr;162(1):156-9 PMID: 2440339
  35. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.
    Science. 1989 Feb 17;243(4893):934-7 PMID: 2537532
  36. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle.
    Cell. 1989 Sep 22;58(6):1097-105 PMID: 2673543
  37. Association of human papillomavirus types 16 and 18 E6 proteins with p53.
    Science. 1990 Apr 6;248(4951):76-9 PMID: 2157286
  38. Suppression of human colorectal carcinoma cell growth by wild-type p53.
    Science. 1990 Aug 24;249(4971):912-5 PMID: 2144057
  39. p53 functions as a cell cycle control protein in osteosarcomas.
    Mol Cell Biol. 1990 Nov;10(11):5772-81 PMID: 2233717
  40. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
    Cell. 1990 Dec 21;63(6):1129-36 PMID: 2175676
  41. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.
    Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5523-7 PMID: 1648218
  42. Participation of p53 protein in the cellular response to DNA damage.
    Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11 PMID: 1933891
  43. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.
    Nature. 1992 Jan 9;355(6356):176-9 PMID: 1530885
  44. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner.
    Cell. 1992 Jan 10;68(1):157-66 PMID: 1531040
  45. Retinoblastoma protein switches the E2F site from positive to negative element.
    Nature. 1992 Jul 16;358(6383):259-61 PMID: 1321348
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1994-06-07
Pages
5320-4
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC43986
Subset
IM
Grants
NIEHS NIH HHS · ES05777 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com